Follicular fluid soluble receptor for advanced glycation end-products (sRAGE): a potential indicator of ovarian

Zaher Merhi1, Mohamad Irani, Angela D Doswell

  • 1Department of Obstetrics, Gynecology, and Reproductive Sciences (Z.M., A.D.D., J.A.), Division of Reproductive Endocrinology and Infertility, University of Vermont College of Medicine, Burlington, Vermont 05401; and Department of Obstetrics and Gynecology (M.I.), Maimonides Medical Center, Brooklyn, New York 11219.

Abstract

Insights

Soluble RAGE (sRAGE) in follicular fluid is linked to ovarian reserve markers like AMH and predicts oocyte yield. Targeting AGEs may improve diminished ovarian response treatments.

Area of Science:

  • Reproductive Endocrinology
  • Ovarian Physiology
  • Molecular Biology

Background:

  • Advanced glycation end-products (AGEs) and their receptor (RAGE) pathway are implicated in abnormal ovarian follicular growth.
  • Soluble RAGE (sRAGE), a circulating form of RAGE, may protect the follicular environment by neutralizing AGEs.

Purpose of the Study:

  • To investigate the association between serum and follicular fluid (FF) sRAGE levels and ovarian reserve markers.
  • To determine if sRAGE levels correlate with factors influencing ovarian response in women undergoing IVF.

Main Methods:

  • Correlated serum anti-Mullerian hormone (AMH) and sRAGE levels in 31 women.
  • Quantified AMH and its receptor (AMHR-II) mRNA in granulosa cells and measured FF sRAGE and AMH protein in 33 women undergoing oocyte retrieval.
  • Measured gene expression, protein concentrations, and oocyte retrieval numbers.

Main Results:

  • Serum sRAGE negatively correlated with BMI but not with age or serum AMH.
  • Higher FF sRAGE levels correlated with lower gonadotropin requirements and predicted the number of oocytes retrieved, independent of age, BMI, or FSH.
  • FF sRAGE positively correlated with FF AMH levels, but no correlation was found with AMH or AMHR-II mRNA levels.

Conclusions:

  • Follicular fluid sRAGE is associated with key measures of ovarian reserve.
  • The role of AGEs in follicular health warrants further investigation.
  • Targeting AGEs could offer therapeutic strategies for diminished ovarian response.